A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers

Next Previous
Trial Profile

A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 23 Mar 2018

At a glance

  • Drugs Abemaciclib (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Eli Lilly

    • Most Recent Events

    • 20 Mar 2018 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
    • 20 Mar 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Sep 2018.
    • 08 Aug 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top